GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLM) » Definitions » Other Stockholders Equity

Apollomics (Apollomics) Other Stockholders Equity : $23.28 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Other Stockholders Equity?

Apollomics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was $23.28 Mil.

Apollomics's quarterly Other Stockholders Equity declined from Dec. 2022 ($10.83 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($23.28 Mil).

Apollomics's annual Other Stockholders Equity increased from Dec. 2021 ($9.85 Mil) to Dec. 2022 ($10.83 Mil) and increased from Dec. 2022 ($10.83 Mil) to Dec. 2023 ($23.28 Mil).

Apollomics Other Stockholders Equity Historical Data

The historical data trend for Apollomics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Other Stockholders Equity Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
- 9.85 10.83 23.28

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial 9.85 - 10.83 - 23.28

Apollomics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Apollomics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Apollomics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLM) » Definitions » Other Stockholders Equity
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLMW:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.